SCHEMBL3511380

SCHEMBL3511380

CC(C)(Oc1cccc(CCC(=O)c2ccc(OC(F)(F)F)cc2)c1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 10/20 0.56
PPARA Q07869 7/20 0.56
PPARD Q03181 1/20 0.50
MAPK14 Q16539 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
GRIN2B Q13224 1/20 0.47
TRPV1 Q8NER1 1/20 0.46
MRGPRX4 Q96LA9 1/20 0.46
FFAR1 O14842 1/20 0.45
CYP4F2 P78329 1/20 0.45
CYP4A11 Q02928 1/20 0.45
CHRM2 P08172 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
CYP19A1 P11511 1/20 0.45
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2031635 0.84 PPARG (0.56) PPARGPPARAPPARDNPC1RAB9A
SCHEMBL3513128 0.82 PPARA (0.55) PPARGPPARAPPARD
SCHEMBL1935430 0.82 PPARA (0.55) PPARGPPARAPPARD
SCHEMBL3512496 0.80 NPC1 (0.47) PPARGPPARAPPARDNPC1RAB9A
Water SCHEMBL11532839 0.78 PPARG (0.63) PPARGPPARAPPARDNPC1RAB9A
SCHEMBL1271844 0.77 FFAR1 (0.67) MAPK14FFAR1CHRM2CHRM1CHRM3
SCHEMBL12083308 0.77 PPARA (0.61) PPARGPPARAPPARDNPC1RAB9A
SCHEMBL3840661 0.76 PPARG (0.71) PPARGPPARAPPARDCYP4F2CYP4A11
SCHEMBL5181367 0.76 CHRM2 (0.56) PPARGPPARAMAPK14NPC1RAB9A
SCHEMBL28012694 0.76 NPC1 (0.59) PPARGNPC1RAB9AGRIN2BTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188148-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-05-29 US claimed
EP-2046716-B1 SUBSTITUTED 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF GENFIT (FR) 2013-08-14 EP disclosed
US-8188148-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-05-29 US disclosed
US-8188148-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-05-29 US disclosed
US-8188148-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-05-29 US disclosed
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2010-11-11 US disclosed
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2010-11-11 US disclosed
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2010-11-11 US disclosed
WO-2007147880-A1 SUBSTITUTED 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF GENFIT (FR) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof DPP3, DPP8, DPP4 PPARG 56/4885PPARA 11/4885PPARD 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.